Pathological abnormalities in the normal-appearing white matter in multiple sclerosis I. V. AllenS. McQuaidG. Nevin Pages: 141 - 144
Clues to the immunopathogenesis of multiple sclerosis by investigating untreated patients during the very early stage of disease M. Söderström Pages: 145 - 149
A case of multiple sclerosis triggered by organic solvents J. ReisJ. L. DietemannC. M. Poser Pages: 155 - 158
Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system C. MoraleJ. BrouwerB. Marchetti Pages: 159 - 162
Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory M. PugliattiS. SotgiuG. Rosati Pages: 163 - 165
Immunogenetic heterogeneity of multiple sclerosis in Sardinia S. SotgiuM. PugliattiG. Rosati Pages: 167 - 170
Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia C. SerraS. SotgiuA. Dolei Pages: 171 - 173
Twenty questions about multiple sclerosis clinical trials methodologies W. Pryse-Phillips Pages: 187 - 193
Non-conventional MR techniques to monitor the evolution of multiple sclerosis M. Filippi Pages: 195 - 200
To treat or not to treat the person with clinical multiple sclerosis – a dilemma A. D. Sadovnick Pages: 205 - 207
Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis A. LugaresiC. CaporaleD. Gambi Pages: 209 - 210